Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Experimental Aging Research|August 1, 1980
Recovery of sexual activity with experience in aged male miceM H Huber, F H BronsonCurrent Problems in Cancer|March 1, 1994
Biology and chemoprevention of head and neck cancerM H Huber, W K HongCurrent Opinion in Oncology|May 1, 1995
Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neckS M Lippman, M R Spitz, M H Huber, et al.Seminars in Oncology|October 1, 1995
Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neckS E Benner, S M Lippman, M H Huber, et al.Investigational New Drugs|January 1, 1994
Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neckM H Huber, M Shirinian, S M Lippman, et al.American Journal of Clinical Oncology|August 1, 1996
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neckM H Huber, S M Lippman, S E Benner, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumorsM H Huber, J S Lee, R A Newman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Phase I evaluation of all-trans-retinoic acid in adults with solid tumorsJ S Lee, R A Newman, S M Lippman, et al.Investigational New Drugs|January 1, 1994
Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neckM H Huber, I W Dimery, S E Benner, et al.Investigational New Drugs|June 9, 1999
Phase I study of paclitaxel administered by ten-day continuous infusionR J Shade, K M Pisters, M H Huber, et al.Pageof 2